AL6 is critical for the response of etiolated Seedlings to JA
We have previously shown that mutants defective in the expression of AL6 display a pleiotropic phenotype when grown on Pi-deplete media, suggesting a role of AL6 in the interpretation of environmental cues [8]. Based on its function as a bona fine histone methylation reader, it can be assumed that AL6 has additional functions, possibly in the response to environmental or developmental conditions that alter the methylation state of lysine residues in histone H3. In the present study, we observed that etiolated al6 seedling produced hypocotyls that were significantly longer than those of the wild type and displayed a severely compromised response to exogenously applied JA. In the wild type, application of 50 µM JA reduced hypocotyl length by 52.8%, an effect which was markedly reduced in al6 mutant plants (Fig. 1A, B). Application of JA to low Pi-grown (low Pi + JA) plants dampened the JA-induced growth inhibition to 37.7 and 21% in wild-type and mutant plants, respectively, indicative of altered JA signalling in Pi-deficient seedlings (Fig. 1A, B). Determination of longitudinal hypocotyl cell lengths revealed a trend towards longer cells in al6 mutants under all conditions, and a marked reduction in both wild-type and mutant plants after application of JA (Fig. 1C-E). Analysis of JA concentrations showed that, except for the anticipated increase of JA levels in JA-treated plants, no differences in internal JA levels were apparent between the genotypes, suggesting that the observed alterations in the JA response between wild-type and al6 mutant plants and among the growth types were not caused by compromised JA biosynthesis (Fig. 1F). Together, these data show that exogenously supplied JA represses skotomorphogenesis of etiolated seedlings, a response that is modulated by the Pi status of the plants. It further appears that functional AL6 is critical for a proper response of dark-grown seedlings to JA.
Chep-p Identified A Comprehensive Subset Of Chromatin-associated Proteins
A ChEP-P approach was used to survey proteins that support, repress, or mediate the interplay of AL6 with chromatin. Essentially, we adopted a protocol described for mammalian cells with various alterations, which proved to be critical to make this method suitable for identifying chromatin-associated proteins in plants (Fig. 2). In particular, formaldehyde crosslinking appears to require special emphasis in the protocol for plants, necessitating a procedure which is similar to that applied for chromatin immunoprecipitation (ChIP) to avoid the dissociation of lowly abundant proteins such as transcription factors. The workflow of ChEP-P, highlighting steps that need adaptation to make this technique applicable to plants, is outlined in Fig. 2.
In total, our ChEP-P survey captured 5,174 unique proteins that were identified by at least two distinct peptides with an FDR < 0.05 when both genotypes and all growth types were considered (Supplementary Dataset S1). Under control conditions, subsets of 3,343 and 2,546 proteins were identified in wild-type and al6 mutant plants, respectively (Fig. 3A). Considering only proteins that were detected in two or more replicates resulted in subsets of 1,425 and 1,608 proteins for the genotypes under study. These numbers remained largely unchanged among the various treatments and genotypes, with large overlaps among the treatments (Fig. 3B). Only samples from al6 plants grown on low Pi media deviated from this pattern. ChEP-P of low Pi-treated al6 seedlings yielded a by 51% higher number of total proteins when compared with plants grown on Pi-replete media, and an 31% increase for low Pi + JA vs + JA-treated al6 plants (Fig. 3A), suggesting a more elaborated response to Pi deficiency in the mutant relative to wild-type plants.
Gene ontology (GO) analysis of the proteins identified in two or more replicates revealed overrepresentation of the molecular process category ‘jasmonic acid biosynthesis’ in both genotypes treated with JA. Also, JA treatment decreased the abundance of proteins involved in translation and, albeit less pronounced, protein folding. Proteins in the category ‘response to oxidative stress’ were more abundant in JA-treated plants. Unexpectedly, this analysis further revealed reduced abundance of proteins related to mRNA binding and rRNA binding in JA-treated plants, the latter trend being more pronounced in wild-type plants (Fig. 3C). A more detailed analysis of the biological process revealed overrepresentation of the categories ‘response to symbiotic fungus’, response to wounding’, ‘oxylipin biosynthesis’ and ‘root development in JA-treated plants, proteins involved in mRNA processing were less prominent in this group of plants (Supplementary Fig. S1). Robust differences between the genotypes were not evident from this analysis.
Chep-p Complements Other Proteomic Approaches
Our ChEP-P dataset is largely complementary to two different proteomic studies using the same material; a suite of proteins defined as the ‘RNA-binding proteome’ [42], and an approach aimed at identifying ubiquitilated proteins [2]. Only a relatively small subset of 71 proteins was identified in all three approaches and can thus be classified as core proteins of etiolated Arabidopsis seedlings (Fig. 4A). Curating proteins derived from the ChEP-P dataset for nuclear localization yielded a suite of 194 chromatin-associated proteins (Table 1). Of those, DNA- and RNA-binding proteins, and proteins involved in histone modifications constitute the largest fractions (Fig. 4C). Moreover, chromatin-binding proteins, DNA transcription factors, and proteins involved in DNA metabolism are better represented in the ChEP-P data set when compared to other approaches (Fig. 4B). For example, ChEP-P identified 6-fold more DNA-binding and 10-fold more chromatin-binding proteins than the study targeting RNA-binding proteins [42], suggesting that ChEP-P is suitable to provide a comprehensive catalogue of proteins that are covalently linked or transiently associated with chromatin. Gene ontology of the nuclear-located proteins revealed pronounced overrepresentation of proteins involved in chromosome organization, DNA damage response, nucleocytoplasmic transport, RNA processing, as well as categories related to stimulus response (Fig. 4D).
Table 1
Chromatin-associated proteins identified by ChEP.
Locus/isoform | Name | Function | Unique peptides | Genotype |
DNA binding | |
At4g21710.1 | NRPB2 | DNA-templated transcription | 6 | WT; al6 |
At4g09000.2 | GRF1 | Regulation of transcription | 13 | WT; al6 |
At1g14410.1 | WHY1 | Regulation of transcription | 5 | WT; al6 |
At2g02740.1 | WHY3 | Regulation of transcription | 8 | WT; al6 |
At4g24800.1 | MRF3 | Regulation of transcription | 13 | WT; al6 |
At1g77180.1 | SKIP | Regulation of transcription | 3 | WT; al6 |
At5g65430.3 | GRF8 | Regulation of transcription | 7 | WT; al6 |
At1g22300.1 | GRF10 | Regulation of transcription | 15 | WT; al6 |
At1g09770.1 | CDC5 | Regulation of transcription | 8 | WT; al6 |
At5g63190.1 | MRF1 | Regulation of transcription | 6 | WT; al6 |
At5g38480.1 | GRF3 | Regulation of transcription | 14 | WT; al6 |
At5g65410.1 | ZHD1 | Regulation of gene expression | 4 | WT; al6 |
At1g15750.1 | TPL | Regulation of transcription | 7 | WT; al6 |
At5g04430.2 | BTR1 | Regulation of transcription | 16 | WT; al6 |
At2g32080.1 | PUR-ALPHA-1 | Regulation of transcription | 3 | WT; al6 |
At2g45640.1 | SAP18 | Regulation of transcription | 4 | WT; al6 |
At2g42560.1 | LEA25 | Unknown function | 7 | al6 |
AT3G58680.1 | MBF1b | Transcriptional coactivator | 4 | al6 |
At3g05060.1 | SAR DNA-binding protein | Box C/D RNP complex | 12 | WT; al6 |
At1g76010.1 | ALBA1 | Chromatin structure | 9 | WT; al6 |
At1g20220.1 | ALBA2 | Chromatin structure | 5 | WT; al6 |
At2g32080.1 | PUR ALPHA-1 | DNA replication | 3 | WT; al6 |
At1g48610.1 | AT-hook motif | DNA binding | 11 | WT; al6 |
At3g42170.1 | DAYSLEEPER | Transposase-like | 8 | WT; al6 |
At3g10690.1 | GYRA | DNA topological change | 12 | WT; al6 |
At5g04130.1 | GYRB2 | DNA topological change | 7 | WT |
At4g25210.1 | DNA-binding storekeeper protein-related | Mediator complex | 2 | WT; al6 |
At4g39680.1 | SAP domain-containing protein | Nucleic acid binding (nucleus) | 18 | WT; al6 |
At4g36020.1 | CSP1 | DNA duplex unwinding | 7 | WT; al6 |
At4g26110.1 | NAP1;1 | DNA repair | 8 | WT; al6 |
At5g10010.1 | HIT4 | Negative regulation of gene silencing | 7 | WT; al6 |
RNA binding | |
At3g49601.1 | pre-mRNA-splicing factor | mRNA splicing | 5 | WT; al6 |
At2g18510.1 | JANUS | mRNA splicing | 3 | WT |
At2g37340.1 | RSZ33 | mRNA splicing | 4 | WT |
At3g55460.1 | SCL30 | mRNA splicing | 6 | WT; al6 |
At3g55220.1 | SAP130B | mRNA splicing | 9 | WT; al6 |
At1g09760.1 | U2A’ | mRNA splicing | 4 | WT; al6 |
At3g61240.1 | RH12 | mRNA binding (nucleus) | 2 | WT; al6 |
At2g14880.1 | SWIB2 | Regulation of transcription by RNA polymerase II | 5 | WT; al6 |
At4g17520.1 | HLN | mRNA binding (nucleus) | 12 | WT; al6 |
At5g39570.1 | PLDRP1 | mRNA binding (nucleus) | 11 | WT; al6 |
At4g34110.1 | PAB2 | mRNA binding (nucleus) | 15 | WT; al6 |
At2g23350.1 | PAB4 | mRNA binding (nucleus) | 17 | WT; al6 |
At5g47210.1 | Hyaluronan | mRNA binding (nucleus) | 18 | WT; al6 |
At1g51510.1 | Y14 | mRNA binding (nucleus) | 3 | WT; al6 |
At5g42820.2 | U2AF35B | mRNA splicing | 3 | WT; al6 |
At1g02140.1 | HAP1 | mRNA splicing | 3 | WT; al6 |
At3g49430.1 | SRP34A | mRNA splicing | 6 | WT; al6 |
At1g49760.1 | PAB8 | mRNA binding (nucleus) | 13 | WT; al6 |
At1g04080.3 | PRP39 | mRNA splicing | 10 | WT; al6 |
At5g04280.1 | RZ1C | mRNA splicing | 7 | WT; al6 |
At3g13570.1 | SLC30A | mRNA splicing | 4 | WT; al6 |
At3g26560.1 | ATP-dependent RNA helicase | mRNA splicing | 2 | WT |
At2g33340.1 | MAC3B | mRNA splicing | 12 | WT; al6 |
At1g80070.1 | SUS2 | mRNA splicing | 22 | WT; al6 |
At4g31580.1 | RSZ22 | mRNA splicing | 7 | WT; al6 |
At4g39260.1 | CCR1 | mRNA splicing | 11 | WT; al6 |
At2g24590.1 | RSZ22A | mRNA splicing | 3 | al6 |
At1g16610.3 | SR45 | mRNA splicing | 3 | WT; al6 |
At1g14650.1 | SWAP | mRNA splicing | 4 | WT; al6 |
At2g13540.1 | ABH1 | mRNA splicing | 4 | WT; al6 |
At5g64270.1 | Splicing factor | mRNA splicing | 11 | WT; al6 |
At2g38770.1 | MAC7 | mRNA splicing | 7 | WT; al6 |
At1g20960.1 | BRR2 | mRNA splicing | 34 | WT; al6 |
At5g41770.1 | Crooked neck protein | mRNA splicing | 3 | WT; al6 |
At5g52040.2 | RS41 | mRNA splicing | 6 | WT; al6 |
At5g54900.1 | RBP45A | mRNA binding (nucleus) | 8 | WT; al6 |
At1g11650.2 | RBP45B | mRNA binding (nucleus) | 5 | WT |
At2g42520.1 | RH37 | mRNA binding (nucleus) | 6 | WT; al6 |
At3g58510.1 | RH11 | mRNA binding (nucleus) | 9 | WT; al6 |
At1g29250.1 | ALBA1 | mRNA-binding (nucleus) | 5 | WT; al6 |
At2g33410.1 | RBGD2 | mRNA-binding (nucleus) | 4 | WT; al6 |
At4g00830.1 | LIF2 | mRNA-binding (nucleus) | 5 | WT; al6 |
At5g07350.2 | TSN1 | mRNA binding (nucleus) | 25 | WT; al6 |
At1g13190.1 | RNA-binding (RRM/RBD/RNP motifs) family protein | mRNA binding (nucleus) | 2 | WT; al6 |
At5g61780.1 | TSN2 | mRNA binding (nucleus) | 22 | WT; al6 |
At3g04610.1 | FLK | mRNA binding, regulation of gene expression | 4 | WT; al6 |
At1g48920.1 | PARL1 | rRNA processing | 24 | WT; al6 |
At5g52470.1 | FIB1 | RNA methylation | 10 | WT; al6 |
At2g21660.1 | CCR2 | mRNA export from the nucleus | 10 | WT; al6 |
At3g10650.1 | NUP1 | mRNA export from the nucleus | 6 | WT; al6 |
At2g05120.1 | NUP133 | mRNA export from the nucleus | 4 | WT; al6 |
At1g14850.1 | NUP155 | Nucleoporin | 12 | WT; al6 |
At1g69250.1 | NTF2 | mRNA export from the nucleus | 4 | al6 |
At2g16950.1 | TRN1 | Nuclear import | 4 | al6 |
At3g06720.1 | IMPA-1 | Nuclear import | 3 | WT; al6 |
At4g16143.1 | IMPA-2 | Nuclear import | 9 | WT; al6 |
At1g09270.1 | IMPA-4 | Nuclear import | 5 | WT; al6 |
At1g75660.1 | XRN3 | miRNA catabolic process | 4 | WT; al6 |
At1g26110.1 | DCP5 | mRNA decapping | 3 | al6 |
AT5G25757.1 | RNA polymerase I-associated factor PAF67 | RNA polymerase I-associated | 9 | WT; al6 |
At2g06990.1 | HEN2 | mRNA processing | 3 | WT; al6 |
At3g03920.1 | H/ACA ribonucleoprotein complex | snoRNA guided rRNA pseudouridine synthesis | 4 | al6 |
At3g57150.1 | NAP57 | mRNA pseudouridine synthesis | 12 | WT; al6 |
DNA repair | | | | |
At3g02540.1 | RAD23C | DNA repair | 3 | al6 |
At5g38470.1 | RAD23D | DNA repair | 3 | WT; al6 |
At4g31880.1 | PDS5C | DNA repair | 15 | WT; al6 |
At5g55660.1 | DEK domain-containing chromatin associated protein | DNA repair | 10 | WT; al6 |
At2g36060.2 | MMZ3 | DNA repair | 4 | WT; al6 |
At2g29570.1 | PCNA2 | DNA repair | 2 | WT; al6 |
At5g47690.1 | PDS5A | DNA repair | 11 | WT; al6 |
At3g04880.1 | DRT102 | DNA repair | 5 | WT; al6 |
Nucleus organization, transport, and chromatin remodeling | | |
At1g74560.3 | NRP1 | Nucleosome assembly | 1 | WT; al6 |
At3g18035.1 | HON4 | Nucleosome assembly | 9 | WT;al6 |
At2g19480.1 | NAP1;2 | Nucleosome assembly | 11 | WT; al6 |
At5g56950.1 | NAP1;3 | Nucleosome assembly | 3 | WT; al6 |
At1g20693.1 | HMGB2 | Chromatin assembly/disassembly | 2 | WT; al6 |
At1g48620.1 | HON5 | Nucleosome assembly | 7 | WT; al6 |
At5g58230.1 | MSI1 | Chromatin assembly | 3 | WT; al6 |
At1g27970.2 | NTF2B | Nucleocytoplasmatic transport | 5 | WT; al6 |
At1g65440.1 | GTB1 | Regulation of transcription; chromatin assembly | 5 | WT; al6 |
At4g26630.1 | DEK3 | Chromatin remodeling | 10 | WT; al6 |
At3g06400.3 | CHR11 | Chromatin remodeling | 2 | WT; al6 |
At5g67630.1 | ISE4 | Chromatin remodeling | 9 | WT; al6 |
At1g67230.1 | LINC1 | Nuclear structure | 18 | WT; al6 |
At4g31430.2 | KAKU4 | Nuclear membrane organization | 5 | WT; al6 |
At5g55190.1 | RAN3 | Nuclear transport of proteins | 8 | WT; al6 |
At2g47970.1 | NPL4 | Nuclear pore localization protein | 5 | WT; al6 |
At4g15900.1 | PRL1 | Protein binding (nucleus) | 6 | al6 |
At5g17020.1 | XPO1 | Nuclear export | 7 | WT; al6 |
At3g44110.1 | ATJ | DNA replication | 4 | WT; al6 |
At2g46520.1 | XPO2 | Protein export from nucleus | 5 | WT; al6 |
At1g79280.2 | NUA | Nuclear transport of proteins | 22 | WT; al6 |
At5g43960.1 | Nuclear transport factor 2 (NTF2) family protein | Nuclear transport of proteins | 6 | WT; al6 |
At1g56110.1 | NOP56 | snoRNA binding | 11 | WT; al6 |
At1g14900.1 | HMGA | Chromosome condensation | 3 | WT; al6 |
At5g20200.1 | Nucleoporin-like protein | Nuclear membrane organization, DNA replication | 6 | WT; al6 |
At5g60980.2 | NTF2 | Nuclear transport | 4 | WT; al6 |
At3g51050.1 | NERD1 | Unidimensional cell growth | 2 | WT; al6 |
At1g19880.1 | RCC1 | Chromosome condensation | 3 | WT; al6 |
At5g11170.1 | UAP56A | RNA-directed DNA methylation | 19 | WT; al6 |
At3g15670.1 | LEA76 | Nuclear protein | 9 | WT; al6 |
At1g15340.1 | MBD10 | Methyl-CpG-binding domain | 7 | WT; al6 |
At1g61000.1 | NUF2 | Kinetochore organization | 1 | WT; al6 |
At5g63860.1 | UVR8 | Chromatin binding | 7 | al6 |
At1g47200.1 | WPP2 | Mitosis | 6 | WT; al6 |
Histone modification |
At5g03740.1 | HDT3 | Histone deacetylation | 7 | WT; al6 |
At2g19520.1 | NFC4 | Histone modification | 8 | WT; al6 |
At5g22650.1 | HAD4 | Histone deacetylation | 5 | WT; al6 |
At5g08450.1 | HDC1 | Histone deacetylation | 4 | WT; al6 |
At4g38130.1 | HD1 | Histone deacetylation | 2 | al6 |
At5g45690.1 | Histone acetyltransferase | Histone acetylation | 13 | WT; al6 |
Chromatin constituents | | | |
At1g08880.1 | HTA5 | Histone superfamily protein | 1 | WT; al6 |
At5g65360.1 | HRT1 | Histone superfamily protein | 4 | WT; al6 |
At2g30620.1 | H1.2 | Histone superfamily protein | 8 | WT; al6 |
At3g46030.1 | HTB11 | Histone superfamily protein | 1 | WT; al6 |
At1g01370.1 | HTR12 | Histone superfamily protein | 2 | al6 |
At5g59970.1 | Histone superfamily protein | Histone superfamily protein | 14 | WT; al6 |
Low Pi only | | | | |
At1g61730.1 | DNA-binding storekeeper protein-related transcriptional regulator | Regulation of transcription | 6 | al6 |
At3g01540.2 | RH141 | rRNA processing | 9 | al6 |
At5g02530.1 | ALY2 | mRNA binding (nucleus) | 3 | al6 |
At2g20490.1 | EDA27 | rRNA pseudouridine synthesis | 3 | WT |
At1g80930.1 | MIF4G domain-containing protein / MA3 domain-containing protein | mRNA splicing | 1 | al6 |
At4g35800.1 | NRBP11 | RNA polymerase II | 8 | WT; al6 |
At3g62310.1 | DEAH RNA helicase homolog PRP43 | mRNA binding (nucleus) | 2 | al6 |
At3g50670.1 | U1SNRNP1 | mRNA splicing | 3 | WT; al6 |
At1g65090.2 | Nucleolin2 | Nucleolar protein | 3 | al6 |
At1g06760.1 | HON11 | Nucleosome positioning | 3 | WT; al6 |
At3g11200.1 | AL21 | Histone binding | 2 | WT |
At1g14510.1 | AL71 | Histone binding | 1 | WT; al6 |
At3g18165.1 | MOS42 | Protein binding (nucleus) | 5 | WT; al6 |
At4g05420.1 | DDB1A | Regulation of transcription | 2 | WT; al6 |
At5g27670.1 | HTA72 | Histone H2A.5 protein | 2 | WT; al6 |
+JA only | | | | |
At3g44600.1 | CYP71 | Chromatin binding | 5 | WT |
At3g50670.1 | U1SNRNP1 | mRNA splicing | 3 | WT; al6 |
At4g32720.1 | LA1 | rRNA processing | 2 | al6 |
At4g35800.1 | NRBP11 | RNA polymerase II | 7 | al6 |
At3g01540.2 | RH141 | rRNA processing | 4 | WT |
At5g53620.1 | MNC6.16 | RNA polymerase II degradation | 2 | al6 |
At4g24270.2 | EMB140 | RNA processing | 3 | al6 |
At1g33240.1 | GTL1 | Negative regulation of transcription | 3 | al6 |
At5g28040.1 | VFP4 | Regulation of transcription | 1 | al6 |
At3g50370.1 | Hypothetical protein | mRNA binding (nucleus) | | |
At2g27100.1 | SE3 | mRNA splicing | 8 | WT; al6 |
At1g06760.1 | HON11 | Nucleosome positioning | 3 | al6 |
At3g11200.1 | AL21 | Histone binding | 3 | WT; al6 |
At3g42790.1 | AL3 | Histone binding | 2 | al6 |
At1g14510.1 | AL71 | Histone binding | 1 | WT; al6 |
At4g27000.1 | RBP45C | mRNA binding (nucleus) | 4 | WT |
At1g23860.1 | RSZ21 | mRNA splicing | 1 | al6 |
At1g65010.1 | Microtubule-associated protein | Reciprocal meiotic recombination | 10 | al6 |
At5g37720.1 | ALY4 | mRNA export from the nucleus | 5 | al6 |
At2g15430.1 | NRPB3 | RNA polymerase II, IV and V | 2 | al6 |
At4g36690.1 | U2AF65A | mRNA splicing | 5 | al6 |
Low Pi + JA only |
At2g27100.1 | SE3 | mRNA splicing | 8 | al6 |
At5g27670.1 | HTA72 | Histone H2A protein | 2 | al6 |
At1g65090.2 | Nucleolin2 | Nucleolar protein | 3 | al6 |
At2g02470.1 | AL6 | Histone binding | 1 | al6 |
At2g41620.1 | Nucleoporin interacting component | mRNA export from the nucleus | 2 | al6 |
At3g18165.1 | MOS42 | Protein binding (nucleus) | 5 | al6 |
At3g11450.1 | ZRF1A | Chromatin silencing | 3 | al6 |
At1g18800.1 | NRP2 | Chromatin assembly | 1 | al6 |
At5g22880.1 | HTB2 | Histone family protein | 1 | WT;al6 |
Proteins identified by ChEP-P in at least two replicates with predominant nuclear localization were considered. 1in low Pi + JA; 2in low Pi and low Pi + JA; 3in +JA and low Pi + JA; WT, wild type. |
A Ppi Network Links Al Proteins To Plant Immunity
As expected from their similar subcellular distribution, most proteins of this core set of nucleus-localized proteins have multiple predicted or validated protein-protein interactions (PPIs), including AL2, AL3, AL6, and AL7 (Fig. 5). A PPI network considering the closest partners of the AL proteins revealed a central position of CELL DEVISION CYCLE 5 (CDC5), a MYB3R- and R2R3-type transcription factor that was shown to control growth and miRNA biogenesis [37, 56]. Together with MODIFIER OF SNC1,4 (MOS4) and the nuclear WD40 protein PLEIOTROPIC REGULATORY LOCUS 1 (PRL1), CDC5 forms the MOS4-Associated Complex (MAC) that confers innate immunity [26, 35, 55]. LHP1-INTERACTING FACTOR 2 (LIF2), another MOS4-interacting protein, also functions in plant innate immunity [23]. Notably, LIF2 was shown to be recruited to chromatin upon JA treatment to regulate the transcription of JA-responsive genes [33]. Moreover, the transcriptome of lif2 mutants is enriched in the category ‘JA-mediated signaling pathway’ [23], underscoring the association of this protein to the response to JA. Conspicuously, LIF2 was found to more abundant in regions enriched in H3K4me3 [33]. Another LHP1-interacting factor, CYCLOPHILIN 71 (CYP71), is involved in chromatin assembly and histone modifications [25]. Further, several proteins involved in nucleosome assembly and organization (NRP2, MSI1, NAP1.2, NAP1.2, NAP1.3, NFA6, and CHR11), histone acetylation (FVE, HDC1, HD1, HD2B, and HD2C), and components of the transcriptional machinery (NRPB1, NRPB2 and NRPB3) are part of this core network. ALFIN-LIKE proteins also have predicted interactions with TPL, a component of the JA repressor complex.
Label-free quantification reveals differences in chromatin dynamics between al6 and the wild type
Label-free quantification was employed to identify proteins that differentially accumulate among the treatments or between the genotypes under study. Only a relatively small subset of chromatin-associated proteins was responsive to JA (Supplementary Dataset S2). Of note, in both genotypes the histone variant HTA5 was upregulated in response to JA, but downregulated in low Pi and low Pi + JA. In wild-type plants, the abundance of RNA-BINDING PROTEIN 45A decreased under all experimental conditions, but the protein was not differentially expressed in al6 seedlings.
In wild-type plants, a subset of 89 proteins was responsive to low Pi and accumulated differentially between treated and control plants (Supplementary Dataset S2). Mutant plants responded to low Pi treatment with the differential expression of a markedly larger subset (140 proteins) of differentially expressed proteins (DEPs); only 35 DEPs were common in the data sets of both genotypes, including HTA5, HTA3, and AL7. The more pronounced Pi deficiency response of al6 mutant plants was also reflected by a more complex pattern of overrepresented GO categories (Fig. 6).
When plants were grown on low Pi + JA media, in both genotypes the histones HTB2 and HTA3 showed increased abundance whereas HTB11 and HTA5 decreased in response to this treatment, pointing to alterations in chromatin organization under these conditions. In wild-type seedlings, low Pi + JA treatment resulted in additive enrichment of GO categories observed upon either growth condition, a pattern which was not observed in mutant plants, in which the response to the combined treatment was rather similar to what was observed with JA alone.
Among the chromatin-associated proteins that were differentially expressed between the two genotypes, the expression of NAP1-RELATED PROTEIN 1 (NRP1) and the related NAP1;2 was highly upregulated in al6 relative to wild-type plants (Supplementary Dataset S3). NAP1 was shown to repress the SRW1 chromatin-remodeling complex [50]. In agreement with such a role of NAP1, the SWR1 component CHROMATIN-REMODELING PROTEIN 11 (CHR11) showed a markedly decreased abundance in al6 mutant plants [30]. Noteworthily, several chromatin-related proteins were either not differentially expressed in response to the experimental treatments, anti-directionally regulated in al6 mutants relative to wild-type plants (e.g., HTA5, HTB11, H1.2, RBP45A), were solely regulated in al6 plants (e.g., CHR11, H2B, and HIGH MOBILITY GROUP), or were anti-directionally regulated in both genotypes (HTB11). Moreover, a suite of genes involved in the biosynthesis of or response to JA (CORI7, GSH1) and auxin biosynthesis (SUR1) were only differentially expressed in wild-type plants (Fig. 7).